首页 | 本学科首页   官方微博 | 高级检索  
检索        

卵磷脂络合碘治疗中心性浆液性脉络膜视网膜病变
引用本文:肖斯贤,曾庆纯,蔡可莉.卵磷脂络合碘治疗中心性浆液性脉络膜视网膜病变[J].中国基层医药,2004,11(11):1316-1317.
作者姓名:肖斯贤  曾庆纯  蔡可莉
作者单位:515041,广东汕头,汕头大学医学院第一附属医院眼科
摘    要:目的 观察卵磷脂络合碘治疗中心性浆液性脉络膜视网膜病变的疗效。方法  4 2例经临床及荧光素血管造影 (FFA)确诊为中心性浆液性脉络膜视网膜病变患者随机分为两组 ,治疗组 2 3例 ,用卵磷脂络合碘 ,1 5mg/次 ,3次 /d ,共 2个月 ;对照组 19例 ,用肌苷片 ,2 0 0mg/次 ,3次 /d ,共 2个月。观察治疗前后视力、眼底变化、视野及FFA改变。结果  1例淘汰。有效率治疗组 90 9% ,对照组 36 8% (P <0 0 1)。结论 卵磷脂络合碘对中心性浆液性脉络膜视网膜病变有明显疗效。

关 键 词:中心性浆液性脉络膜视网膜病变  络合碘  治疗中  对照组  治疗组  FFA  卵磷脂  目的观  结论  视野
修稿时间:2004年3月22日

Effects of Jolethin on central serous chorioretinopathy
XIAO Si xian,ZENG Qing chun,CAI Ke li.Effects of Jolethin on central serous chorioretinopathy[J].Chinese Journal of Primary Medicine and Pharmacy,2004,11(11):1316-1317.
Authors:XIAO Si xian  ZENG Qing chun  CAI Ke li
Institution:XIAO Si xian,ZENG Qing chun,CAI Ke li.Department of Ophthalmology,First Affiliated Hospital,Shantou University Medical College,Guangdong,515041,China
Abstract:Objective To investigate the effects of jolethin on central serous chorioretinopathy(CSC).Methods 42 patients with CSC diagnosed by clinic and fundus fluorescein angiography(FFA) were randomly divided into two groups.23 patients(23 eyes) as treatment group received jolethin three times a day for 2 months and 19 patients(19 eyes) as control group received inosine three times a day for 2 months.The changes of visual acuity,ophthalmoscopic sign,visual field and FFA before and after treatment were observed.Results 1 patients(1 eye) loss of follow up.The effective rate was 90.9% in the treatment group and 36.8% in the control group(P<0.01).Conclusion Jolethin has remarkable effects in the treatment of CSC.
Keywords:Jolethin  Central serous chorioretinopathy  Treatment
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号